Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks. | Cancers (Basel) | 2021 | 33922595 | PubTator, text mining | PubMed |
| The Role of RNA in DNA Breaks, Repair and Chromosomal Rearrangements. | Biomolecules | 2021 | 33918762 | PubTator, text mining | PubMed |
| Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining. | Nat Commun | 2021 | 33911081 | PubTator, text mining | PubMed |
| Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients. | Sci Rep | 2021 | 33903686 | PubTator, text mining | PubMed |
| DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing. | Trends Genet | 2021 | 33896583 | PubTator, text mining | PubMed |
| Measuring nonhomologous end-joining, homologous recombination and alternative end-joining simultaneously at an endogenous locus in any transfectable human cell. | Nucleic Acids Res | 2021 | 33877327 | PubTator, text mining | PubMed |
| HPF1-dependent PARP activation promotes LIG3-XRCC1-mediated backup pathway of Okazaki fragment ligation. | Nucleic Acids Res | 2021 | 33872376 | PubTator, text mining | PubMed |
| Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients. | Oncotarget | 2021 | 33868589 | PubTator, text mining | PubMed |
| Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma. | Oncol Lett | 2021 | 33868481 | PubTator, text mining | PubMed |
| CRISPR/Cas9 ribonucleoprotein-mediated knockin generation in hTERT-RPE1 cells. | STAR Protoc | 2021 | 33855309 | PubTator, text mining | PubMed |
| Structural basis of long-range to short-range synaptic transition in NHEJ. | Nature | 2021 | 33854234 | Swiss-Prot, curated | PubMed |
| Reciprocal regulation of RIG-I and XRCC4 connects DNA repair with RIG-I immune signaling. | Nat Commun | 2021 | 33846346 | PubTator, text mining | PubMed |
| Functional analysis of XRCC4 mutations in reported microcephaly and growth defect patients in terms of radiosensitivity. | J Radiat Res | 2021 | 33842963 | PubTator, text mining | PubMed |
| Chlamydomonas POLQ is necessary for CRISPR/Cas9-mediated gene targeting. | G3 (Bethesda) | 2021 | 33836052 | PubTator, text mining | PubMed |
| Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond. | Front Oncol | 2021 | 33816244 | PubTator, text mining | PubMed |
| Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' Heel. | Cancers (Basel) | 2021 | 33808562 | PubTator, text mining | PubMed |
| A Tale of Ice and Fire: The Dual Role for 17β-Estradiol in Balancing DNA Damage and Genome Integrity. | Cancers (Basel) | 2021 | 33808099 | PubTator, text mining | PubMed |
| DNA Damage Response during Replication Correlates with CIN70 Score and Determines Survival in HNSCC Patients. | Cancers (Basel) | 2021 | 33801877 | PubTator, text mining | PubMed |
| CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research. | Int J Mol Sci | 2021 | 33801123 | PubTator, text mining | PubMed |
| Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors? | J Pers Med | 2021 | 33800556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=45